Literature DB >> 22398597

Cystic fibrosis drug Vertex's latest triumph.

Heidi Ledford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398597     DOI: 10.1038/nbt0312-201a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Breathing easier with combinations.

Authors:  Anna Azvolinsky
Journal:  Nat Biotechnol       Date:  2015-11       Impact factor: 54.908

2.  Foundation receives $3.3-billion windfall for Kalydeco.

Authors:  Melanie Senior
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

3.  FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug label.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2017-07-12       Impact factor: 54.908

Review 4.  Computed tomography dose optimisation in cystic fibrosis: A review.

Authors:  Helena Ferris; Maria Twomey; Fiachra Moloney; Siobhan B O'Neill; Kevin Murphy; Owen J O'Connor; Michael Maher
Journal:  World J Radiol       Date:  2016-04-28

Review 5.  Computed tomography in cystic fibrosis lung disease: a focus on radiation exposure.

Authors:  Stella Joyce; Brian W Carey; Niamh Moore; David Mullane; Michael Moore; Mark F McEntee; Barry J Plant; Michael M Maher; Owen J O'Connor
Journal:  Pediatr Radiol       Date:  2021-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.